openPR Logo
Press release

Paying It Forward: Bringing 30 Years Of Success To Artists In All Musical Genres

09-09-2013 05:57 PM CET | Leisure, Entertainment, Miscellaneous

Press release from: Mi2N

Cross Music Group, Chattanooga, TN {August 22, 2013} With a 30-year track record of success in gospel music including numerous #1's and Song of the Years, award-winning songwriter, artist and producer Phil Cross is working with artists outside the gospel genre with the launch of Phil Cross Productions, a new division of Cross Music Group. Phil Cross Productions encompasses all aspects of artist management including audio recording, video, photography and graphic design, as well as marketing services, artist management and branding.

With his many achievements in gospel music, Cross has been one of the premier artists and songwriters in the genre for several decades. But in addition to his ongoing songwriting and performance career, Cross has a passion for mentoring the careers of other artists, and believes that his success in the gospel industry will translate to other genres as well. " I want to share my talent and expertise with today's artists, helping them go beyond what they ever thought possible as they connect with Phil Cross Productions. I can provide Nashville quality recording and video production as well as photography, graphic and social media services, without the Nashville price tag. Thanks to the internet, artists can get their music to the fans directly without a record label, but conversely artists must present a quality product in order to stand out. I can help artists with the right talent move their careers to the next level. "

Phil Cross Productions is a division of Cross Music Group, Inc. based in Chattanooga, TN. The mission of Phil Cross Productions is to offer artist management services targeted towards independent artists who have what it takes to be successful in country, bluegrass, contemporary Christian and gospel. We offer comprehensive services at affordable rates.

For more information contact Karen Phillips @ 423-503-8764. For a complete listing of services, visit Phil Cross Productions http://philcrossmusic.com/

About Phil Cross
Phil Cross is known as a one of today's most anointed Christian music artists and is highly regarded as a composer, singer, and speaker. He has penned almost 1000 songs and received many of Gospel Music's highest honors including numerous Dove Awards, Song Of The Year, Songwriter and Entertainer of the Year honors. Some of Phil's notable compositions include: "I Am Redeemed," "Champion of Love," "One Holy Lamb," "Yes I Am," "When I Get Carried Away" and many more.

Announcing the launch of Phil Cross Productions, offering services including recording, video, artist management and marketing.

tel: 718 278 0662
ecfont@musicdish.net
1814 Astoria Blvd., Astoria, NY 11102

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Paying It Forward: Bringing 30 Years Of Success To Artists In All Musical Genres here

News-ID: 269930 • Views:

More Releases for Cross

Platelet and Plasma markets Share Trends Analysis Growth: America's Blood Center …
Rising incidence of haemophilia, thrombocytopenia, autoimmune diseases as well as other infectious and rare disease will serve to be a key driver for the platelet and plasma market growth. According to American Academy of Neurology, plasma can be used for treatment of various neurological conditions. Plasma exchange process involves replacing plasma in a person’s blood. This process can be used for treatment of conditions such as inflammatory dysimmune neuropathies, multiple
Platelet and Plasma Market 2018: Study on Top Players | America’s Blood Center …
Platelet and Plasma Market size is set to exceed USD 6.5 billion by 2024; according to a new research report by Global Market Insights. Increasing prevalence of chronic diseases such as liver cirrhosis, non-alcoholic steato-hepatitis (NASH) hepatocellular carcinoma and other liver diseases will fuel the market growth during the foreseeable years. Liver diseases are the fifth most common cause of mortality across the world. According to American Association for the Study
Platelet and Plasma Market Prominent Players – America’s Blood Centers, Amer …
Platelet and Plasma Market size is set to exceed USD 6.5 billion by 2024; according to a new research report by Global Market Insights. Increasing prevalence of chronic diseases such as liver cirrhosis, non-alcoholic steato-hepatitis (NASH) hepatocellular carcinoma and other liver diseases will fuel the market growth during the foreseeable years. Liver diseases are the fifth most common cause of mortality across the world. According to American Association for the
Platelet and Plasma Market : Illustrious Companies - America’s Blood Centers, …
Platelets And Plasma Market will exceed USD 6.5 billion by 2024; as per a new research report. Increasing number of blood transfusion in regions such as Europe will drive the growth of platelets and plasma market over the forecast period. Millions of people receive donated blood and its components each year. As per the statistics of the European commission over 20 million units of blood or blood components were transfused in
Platelet and Plasma Market : Study on Key Players | America’s Blood Centers, A …
Platelet and Plasma Market size is set to exceed USD 6.5 billion by 2024; according to a new research report by Global Market Insights.Growing number of blood transfusions globally is another impact rendering factor for the growth of platelets and plasma market. According to European commission’s 2017 annual report, more than 25 million units of blood and blood components were being issued for the purpose of transfusion in Europe. Blood
Platelet and Plasma Market : Study on Eminent Players | America’s Blood Center …
Platelet and Plasma Market size is set to exceed USD 6.5 billion by 2024; according to a new research report by Global Market Insights. Increasing prevalence of chronic diseases such as liver cirrhosis, non-alcoholic steato-hepatitis (NASH) hepatocellular carcinoma and other liver diseases will fuel the market growth during the foreseeable years. Liver diseases are the fifth most common cause of mortality across the world. According to American Association for the Study